Cardlytics Continues Revenue Tightening Amidst Failing Business Economics (NASDAQ: CDLX)

.Financial article writer highly recommends selling Cardlytics, Inc. because of declining device business economics, revenue difficulties, and also bad monetary trends. Click on for this CDLX improve.